These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease. Iqbal S; Anantha Krishnan D; Gunasekaran K J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053 [TBL] [Abstract][Full Text] [Related]
3. In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives. Faris A; Hadni H; Ibrahim IM; Elhallaoui M J Biomol Struct Dyn; 2024 Jun; 42(9):4817-4833. PubMed ID: 37338041 [TBL] [Abstract][Full Text] [Related]
4. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors. Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133 [TBL] [Abstract][Full Text] [Related]
5. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study. Choubey SK; Jeyaraman J J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885 [TBL] [Abstract][Full Text] [Related]
6. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation. Qiu Y; Zhou L; Hu Y; Bao Y J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691 [TBL] [Abstract][Full Text] [Related]
7. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine. Chaudhari HK; Pahelkar A Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898 [TBL] [Abstract][Full Text] [Related]
8. Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations. Melge AR; Kumar LG; K P; Nair SV; K M; C GM J Biomol Struct Dyn; 2019 Nov; 37(18):4747-4766. PubMed ID: 30580670 [TBL] [Abstract][Full Text] [Related]
9. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors. Sharma A; Thelma BK J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362 [TBL] [Abstract][Full Text] [Related]
10. Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3). Kaur M; Silakari O J Biomol Struct Dyn; 2017 Nov; 35(14):3043-3060. PubMed ID: 27678281 [TBL] [Abstract][Full Text] [Related]
11. Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies. Bhujbal SP; He W; Hah JM Molecules; 2022 Sep; 27(19):. PubMed ID: 36234844 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches. Nada H; Lee K; Gotina L; Pae AN; Elkamhawy A Comput Biol Med; 2022 Mar; 142():105217. PubMed ID: 35032738 [TBL] [Abstract][Full Text] [Related]
13. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches. Jana S; Singh SK J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408 [TBL] [Abstract][Full Text] [Related]
14. Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors. Waldschmidt HV; Bouley R; Kirchhoff PD; Lee P; Tesmer JJG; Larsen SD Bioorg Med Chem Lett; 2018 May; 28(9):1507-1515. PubMed ID: 29627263 [TBL] [Abstract][Full Text] [Related]